yohimbine has been researched along with Diabetes Mellitus, Adult-Onset in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, LE; Axelsson, AS; Groop, LC; Mulder, H; Renström, E; Rosengren, AH; Spégel, P; Tang, Y | 1 |
| Hayashi, Y; Kitamura, T; Kobayashi, H; Kobayashi, M; Matozaki, T; Murata, Y; Ohnishi, H; Okazawa, H | 1 |
| Fatima, A; Rahimnajjad, MK; Tanweer, MS | 1 |
| Ishii-Nozawa, R; Mita, M; Shoji, M; Takeuchi, K | 1 |
| Adorjan, I; Bauer, L; Belz, M; Brunmair, B; de Cillia, VA; Fenzl, A; Frobel, K; Fürnsinn, C; Gruber, D; Lehner, Z; Luger, A; Rustenbeck, I; Stadlbauer, K | 1 |
| Henriksnäs, J; Jansson, L; Pettersson, U; Sandberg, M | 1 |
| Anunciado, RV; Horio, F; Imamura, T; Kobayashi, M; Namikawa, T; Niki, I; Teradaira, S | 1 |
| Burgdorf, C; Dendorfer, A; Kurz, T; Richardt, G; Schütte, F | 1 |
| Abdel-Zaher, AO; Ahmed, IT; El-Koussi, AD | 1 |
1 trial(s) available for yohimbine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist.
Topics: Adrenergic alpha-2 Receptor Antagonists; Aged; Alleles; Blood Pressure; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Gene Expression; Genetic Variation; Genotype; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, alpha-2; Translational Research, Biomedical; Yohimbine | 2014 |
8 other study(ies) available for yohimbine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Expression of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 in pancreatic beta-Cells and its role in promotion of insulin secretion and protection against diabetes.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Glucose; CD47 Antigen; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, Atherogenic; Feeding Behavior; Female; Glucose Intolerance; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutant Proteins; Receptors, Immunologic; Yohimbine | 2008 |
Yohimbine can be the new promising therapy for erectile dysfunction in type 2 diabetics.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Erectile Dysfunction; Humans; Insulin-Secreting Cells; Male; Receptors, Adrenergic, alpha-2; Yohimbine | 2010 |
Dysfunction of neurotransmitter modulation system on adrenergic nerves of caudal artery in type 2 diabetic Goto-Kakizaki rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Neurons; Animals; Arteries; Clonidine; Diabetes Mellitus, Type 2; Electric Stimulation; In Vitro Techniques; Norepinephrine; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Adenosine A2; Sympathetic Nervous System; Yohimbine | 2012 |
Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Brimonidine Tartrate; Calcium; Cells, Cultured; Diabetes Mellitus, Type 2; Diazoxide; Female; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; KATP Channels; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Quinoxalines; Yohimbine | 2012 |
The α2-adrenoceptor antagonist yohimbine normalizes increased islet blood flow in GK rats: a model of type 2 diabetes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Anesthesia; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Injections, Intravenous; Islets of Langerhans; Male; Pancreas; Rats; Rats, Inbred WF; Regional Blood Flow; Yohimbine | 2013 |
The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Animals, Wild; Blood Glucose; Clonidine; Crosses, Genetic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Epinephrine; Female; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Yohimbine | 2005 |
Impairment of presynaptic alpha2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Glucose; Body Weight; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Electric Stimulation; Heart Failure; Heterozygote; Homozygote; Male; Norepinephrine; Organ Size; Perfusion; Quinoxalines; Rats; Rats, Zucker; Receptors, Adrenergic, alpha-2; Receptors, Presynaptic; Yohimbine | 2006 |
The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Insulin; Male; Rabbits; Rats; Rats, Wistar; Vasodilation; Yohimbine | 2001 |